Researchers from Naya Biosciences Inc. and collaborators presented preclinical data on NY-303, a natural killer (NK) cell engager bispecific antibody targeting both GPC3 and NKp46. NKp46 is a cell ...

Innate Pharma's cancer programs, including partnerships with big pharma, show promise. Find out why IPHA stock could offer ...

Analysis - A fascinating new study, published in the Journal of Clinical Investigation, has revealed an unexpected potential benefit of severe COVID infection: it may help shrink cancer.

This surprising finding opens up new possibilities for cancer treatment and sheds light on the complex interactions between ...

A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...

Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions and inflammation, primarily in the folds of the skin. It ...

Researchers discovered that severe COVID infection causes the body to produce a special type of monocyte with anti-cancer ...

(Web Desk) - Scientists have made a groundbreaking discovery linking Covid to cancer regression, potentially opening new ...